COLLPLANT BIOTECH. IS-01 (F:CPT) — Market Cap & Net Worth

$4.34 Million USD · €3.71 Million EUR · Rank #28817

Market Cap & Net Worth: COLLPLANT BIOTECH. IS-01 (CPT)

COLLPLANT BIOTECH. IS-01 (F:CPT) has a market capitalization of $4.34 Million (€3.71 Million) as of June 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #28817 globally and #2498 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying COLLPLANT BIOTECH. IS-01's stock price €0.27 by its total outstanding shares 14415128 (14.42 Million). Review CPT total liabilities to assess the company's total debt and financial obligations.

COLLPLANT BIOTECH. IS-01 Market Cap History: 2026 to 2026

COLLPLANT BIOTECH. IS-01's market capitalization history from 2026 to 2026. Data shows growth from $4.48 Million to $4.48 Million (0.00% CAGR).

COLLPLANT BIOTECH. IS-01 Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how COLLPLANT BIOTECH. IS-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of CPT by Market Capitalization

Companies near COLLPLANT BIOTECH. IS-01 in the global market cap rankings as of June 19, 2026.

Key companies related to COLLPLANT BIOTECH. IS-01 by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#221	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$110.45 Billion	$451.63
#445	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$62.84 Billion	$609.94
#547	UCB SA	BR:UCB	$49.68 Billion	€249.20
#573	Argen-X	BR:ARGX	$47.14 Billion	€762.80

COLLPLANT BIOTECH. IS-01 Historical Marketcap From 2026 to 2026

Between 2026 and today, COLLPLANT BIOTECH. IS-01's market cap moved from $4.48 Million to $ 4.48 Million, with a yearly change of 0.00%.

Year	Market Cap	Change (%)
2026	€4.48 Million	--

End of Day Market Cap According to Different Sources

On Jun 19th, 2026 the market cap of COLLPLANT BIOTECH. IS-01 was reported to be:

Source	Market Cap
Yahoo Finance	$4.34 Million USD
MoneyControl	$4.34 Million USD
MarketWatch	$4.34 Million USD
marketcap.company	$4.34 Million USD
Reuters	$4.34 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About COLLPLANT BIOTECH. IS-01

F:CPT Germany Biotechnology

Market Cap

$4.48 Million

€3.83 Million EUR

Market Cap Rank

#28817 Global

#2498 in Germany

Share Price

€0.27

Change (1 day)

+0.00%

52-Week Range

€0.15 - €1.83

All Time High

€1.83